A detailed history of Thomas Story & Son LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Thomas Story & Son LLC holds 61,208 shares of JNJ stock, worth $8.91 Million. This represents 4.04% of its overall portfolio holdings.

Number of Shares
61,208
Previous 61,140 0.11%
Holding current value
$8.91 Million
Previous $8.94 Million 11.0%
% of portfolio
4.04%
Previous 3.86%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$145.48 - $167.38 $9,892 - $11,381
68 Added 0.11%
61,208 $9.92 Million
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $9,095 - $9,940
63 Added 0.1%
61,140 $8.94 Million
Q1 2024

Apr 30, 2024

SELL
$155.22 - $162.74 $776 - $813
-5 Reduced 0.01%
61,077 $9.66 Million
Q4 2023

Feb 29, 2024

SELL
$145.6 - $158.88 $1,456 - $1,588
-10 Reduced 0.02%
61,082 $9.57 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $1.31 Million - $1.47 Million
-8,434 Reduced 12.13%
61,092 $9.52 Million
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $27,937 - $30,065
181 Added 0.26%
69,526 $11.5 Million
Q1 2023

Apr 21, 2023

SELL
$151.05 - $180.26 $11,328 - $13,519
-75 Reduced 0.11%
69,345 $10.7 Million
Q4 2022

Jan 27, 2023

SELL
$160.2 - $179.79 $350,998 - $393,919
-2,191 Reduced 3.06%
69,420 $12.3 Million
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $108,091 - $120,278
-670 Reduced 0.93%
71,611 $11.7 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $30,274 - $33,481
-180 Reduced 0.25%
72,281 $12.8 Million
Q1 2022

May 02, 2022

BUY
$158.14 - $179.59 $353,917 - $401,922
2,238 Added 3.19%
72,461 $12.8 Million
Q4 2021

Feb 04, 2022

SELL
$155.93 - $173.01 $677,515 - $751,728
-4,345 Reduced 5.83%
70,223 $12 Million
Q3 2021

Oct 22, 2021

SELL
$161.5 - $179.47 $1.09 Million - $1.21 Million
-6,741 Reduced 8.29%
74,568 $12 Million
Q2 2021

Aug 02, 2021

SELL
$159.48 - $171.07 $421,824 - $452,480
-2,645 Reduced 3.15%
81,309 $13.4 Million
Q1 2021

Apr 30, 2021

BUY
$153.07 - $170.48 $8,878 - $9,887
58 Added 0.07%
83,954 $13.8 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $55,529 - $63,738
-405 Reduced 0.48%
83,896 $13.2 Million
Q3 2020

Oct 23, 2020

SELL
$140.38 - $153.83 $18,951 - $20,767
-135 Reduced 0.16%
84,301 $12.6 Million
Q2 2020

Aug 03, 2020

SELL
$128.81 - $155.51 $490,766 - $592,493
-3,810 Reduced 4.32%
84,436 $11.9 Million
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $12,781 - $17,708
115 Added 0.13%
88,246 $11.6 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $19,125 - $21,966
150 Added 0.17%
88,131 $12.9 Million
Q3 2019

Nov 05, 2019

SELL
$126.95 - $142.14 $82,390 - $92,248
-649 Reduced 0.73%
87,981 $11.4 Million
Q2 2019

Jul 29, 2019

BUY
$131.15 - $144.24 $277,644 - $305,356
2,117 Added 2.45%
88,630 $12.3 Million
Q4 2018

Jan 18, 2019

SELL
$122.84 - $147.84 $9,213 - $11,088
-75 Reduced 0.09%
86,513 $11.2 Million
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $5,970 - $6,588
-50 Reduced 0.06%
86,588 $10.5 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $87,570 - $103,697
-700 Reduced 0.8%
86,638 $11.1 Million
Q4 2017

Jan 29, 2018

SELL
$131.22 - $143.62 $1.04 Million - $1.14 Million
-7,925 Reduced 8.32%
87,338 $12.2 Million
Q3 2017

Nov 02, 2017

BUY
$129.47 - $135.38 $12.3 Million - $12.9 Million
95,263
95,263 $12.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Thomas Story & Son LLC Portfolio

Follow Thomas Story & Son LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas Story & Son LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thomas Story & Son LLC with notifications on news.